RT by @EU_Health: Today, I met with @EORTC representatives: non-commercial clinical trials are instrumental to optimise treatments, improve outcomes, and support accessible, tailored cancer care, enhancing patients’ quality of life.

The #BiotechAct and #PharmaReform will help make this easier.
---
https://nitter.net/OliverVarhelyi/status/2023744840513564724#m

Europe urged to fill US mRNA tech gap: Recent US retreat in mRNA vaccines and therapies could open the door for Europe in its upcoming #BiotechAct. https://www.euractiv.com/section/health-consumers/news/eu-risks-biotech-setback-if-mrna-tech-is-left-out-of-biotech-act/?utm_source=mastodon&utm_medium=dlvr.it